Work

Glofitamab plus polatuzumab vedotin: a novel safe, and highly effective chemotherapy-free regimen for pediatric relapsed/refractory B-cell non-Hodgkin lymphoma

Year: 2026

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2026.300836

Authors: Siqi Dong, Meng Wang, Ziyan Luo, Weizhe Wu, Haiying Huang, Jianping Yang, Yufeng Liang, Hua Jiang, Lin Qiu

Institutions: Guangzhou Women and Children Medical Center, Guangzhou Medical University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

OpenAlex ID: W7165168506

FWCI:

Cites:

Cited by:

Related to: